Neuromuscular Flashcards
History of MG
Long known to physicians, perhaps back to the 17th century and Sir Thomas Willis
Called myasthenia gravis by Jolly (1895)
One of the first known “auto-immune” diseases
Still best defined as a “fatiguing WEAKNESS” but NOT fatigue alone
Predilection for muscles innervated by the cranial nerves, and less often the spinal nerves
Found in approximately 1 in 10,000 Americans
More common in women than in men before age 40, then about equal in men and women
Immunological basis of myasthenia
THYMOMAS in about 10 - 15% of patients, and hyperplasia in 70% of patients’ thymuses
Disease could be transferred to animals with injection of a patient’s IgG
Electron microscopy showed deposition of immune complexes on the postsynaptic membrane, specifically the Ach receptors
Binding of antibodies may be at many different sites on the ACh receptor (AChR): the major pathology is immune-mediated DESTRUCTION of AChRs more than simple BLOCKING of AchRs
MG Patient presentations
Generally increasing weakness over weeks or months, but may seem abrupt with diplopia or loss of speech or swallowing
At first presentation, about 40% of patients have EYE involvement; eventually over 90 % of patients have: ptosis, diplopia, or inability to close eyes completely
Usually extraocular muscles in both eyes are affected, in a way that cannot be explained only by disease of CNs 3, 4, 6 or 7
Also common is fatiguing weakness of speech and swallowing
- Power of voice decreases quickly, restored by pausing
- Chewing and swallowing become increasingly difficult; also restored by pausing or resting during meals
In severe cases, normally much later: weakness of limbs, difficulty with neck flexion and extension, and respiratory failure
Who gets MG?
Seemingly young women, especially around pregnancy or childbirth, in 20s 30s OR
Older men, 50s, 60s, 70s
More common in patients with other autoimmune disorders including hyperthyroidism and perhaps Systemic Lupus Erythematosus
Patients often considered depressed or simply hysterical at first for complaining of weakness, yet the arms and legs are usually strong and reflexes are normal, and they always regain strength after a brief rest or nap
Course of Myasthenia Gravis
Can be severely progressive in some patients
Prognosis often clear in the first two years
Some will only have ocular symptoms, and if the only symptoms are ocular after 2 years, unlikely to spread
Some patients have a slow decline, but others may have a MYASTHENIC CRISIS:
1. Severe impairment of swallowing, even their own secretions, and respiratory impairment, causing aspiration pneumonia, and may require intubation and mechanical ventilation
Diagnosis of Myasthenia
Easy when there is a combination of bilateral ptosis, generally worse in one eye, with multiple extra-ocular palsies, or weakness of voice, swallowing or facial expression
More difficult when there is only ptosis of one eye, or only dysarthria, or only dysphagia
Typically patients are strongest in the morning, and then become weaker during the course of the day
Usually no changes in reflexes, and no sensory changes or cerebellar involvement, or ANS effects
Diagnostic aids for myasthenia
Circulating antibodies to skeletal muscles in perhaps 80 – 90% of patients with generalized myasthenia, but only 60 - 70% of patients with strictly ocular involvement have these antibodies
Anti-striated muscle antibodies are more commonly positive in patients who have a thymoma than in patients who do not
Nerve conduction studies show a DECREMENTAL RESPONSE; at slow rates of repetitive stimulation (@3HZ) the size of the muscle electrical response keeps declining
CT or MRI of the chest to look for a thymoma; if present it should be removed if possible
Consider MRI of the brain if there is only ocular involvement: rarely tumors of the orbital region or brainstem may “mimic” myasthenia gravis
Laboratory tests for thyroid disease or auto-immune disorders
The Tensilon (Edrophonium) Test
Tensilon (edrophonium) is a short-acting cholinesterase inhibitor, which allows acetylcholine to last longer at the NMJ (nicotinic as well as muscarinic), and therefore briefly overcome myasthenia gravis
Atropine, an anti-muscarinic, is first injected to limit bradycardia from muscarinic receptors
Then 1-2 mg of Tensilon is given IV as a test
If no problems, up to 10 mg of Tensilon is given; maximum effect is seen in 1 to 5 minutes
Treatment of MG
Generally start with an oral cholinesterase inhibitor, such as pyridostigmine (Mestinon) 60mg, twice a day going slowly up to four or five times a day
Adverse effects: intestinal cramping, diarrhea, nausea, bradycardia, sweating
Long acting form of Mestinon, 180mg Timespan, can be given at bedtime to help patients the next morning
steroids and MG
Many patients will also need corticosteroids, such as Prednisone
Patients may begin with high doses, 60 – 90mg/day, but consider hospitalization, since prednisone somehow can worsen myasthenia when first given
A. Eventually patients may do well on lower dosages of prednisone
B. Precautions for GERD, ulcers, diabetes, osteoporosis, cataracts, hypokalemia, etc
Other immunosuppressants sometimes: azathioprine, cyclophosphamide, mycophenolate (CellCept)
Severe myasthenia
May respond to plasmapheresis, which removes many of the patient’s own immunoglobulins
May also respond to intravenous IgG (IVIG)
Cholinergic crisis: worsening from use of too much cholinesterase inhibitors
Steroid myopathy: weakness from prolonged use of steroids
Some drugs may worsen myasthenia gravis, including antibiotics (aminoglycosides), anticonvulsants, anesthetics
Amyotrophic Lateral Sclerosis history
Discovered in the mid 1800s, mostly by the great French neurologist Jean Martin Charcot
Known in most of the world as Charcot Disease
Known to most Americans as Lou Gehrig’s Disease, of course
A loss of nearly motor function by the time of death, with both peripheral motor neuron and corticospinal tact disease in most patients
Amyotrophic Lateral Sclerosis
Pathologically a disease of upper and lower motor neurons, so increasing weakness is what is one expects to find in patients, atrophy, fasciculations and usually HYPEREFLEXIA
However, asymmetric weakness often occurs
Some complaints of numbness and pain are expressed by patients early in the disease, somehow
Few patients notice diffuse weakness at first
Predilection for certain muscles: the forearms and hands, tongue, larynx, pharynx, muscles of facial expression, lower extremity, respiratory muscles at the end
Virtually NO INVOLVEMENT of extraocular muscles
ALS: Early Features
Presenting symptoms:
Dysarthria 33%
Painless loss of hand function 20
Weak, wasted shoulder 14
Foot drop 12
Fasciculations/cramps 11
Exercise intolerance 4
Respiratory failure 4
Cognitive impairment 2
Amyotrophic Lateral Sclerosis- what’s going on
Gradual cell death of both upper motor neurons and lower motor neurons
Weakness, fasciculations, atrophy, yet increased deep tendon reflexes
Prominent effects on lower brainstem and cervical spinal cord: speech may be impaired especially early in the course;
Upper motor neurons: motor (frontal) cortex, via corticospinal tracts, to all levels of the brain stem and spinal cord
Lower motor neurons: anterior horn of spinal cord to skeletal muscles